Kerry L Burnstein

6PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 18, 2026
BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

|Oct 10, 2023
Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens.

Rolando D Z Lyles, Maria J Martinez, Benjamin Sherman

|May 03, 2022
Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans.

Laine M Heidman, Nahuel Peinetti, Valeria A Copello

|Apr 14, 2022
The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor.

Valeria A Copello, Kerry L Burnstein

|Jun 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.

Ning Zhao, Stephanie O Peacock, Chen Hao Lo

|Aug 16, 2018
Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer.

Fiorella Magani, Eric R Bray, Maria J Martinez

Pageof 1

Frequent Collaborators

4 joint publications

Valeria A Copello

2 joint publications

Laine M Heidman

2 joint publications

Maria Julia Martinez

2 joint publications

Rolando Dz Lyles